An alternative perspective on how laboratory medicine can contribute to solve the health care crisis

A model to save costs by acquiring excellence in diagnostic systems

Michele Mussap

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The rapid escalation in health care costs has led to the idea to deliver better care at lower costs, reshaping the responsibilities of the health care system to achieve the goal of creating value for the patient. The pressure for fiscal containment and the progressive reduction in available health care resources originated very short term strategies consisting of abrupt reductions in expenditure, specifically in the provision of clinical pathology laboratory medicine services. However, the impact of laboratory test results on diagnostic and therapeutic interventions has increased enormously in the past decade, due to advances in personalized medicine and to the strictly correlated requirement to use new biomarkers with increasing sensitivity and specificity in clinical practice. In order to create savings by delivering better care there is the need to invest financial resources in purchasing high technology and new sophisticated tests and to promote the expertise of clinical pathologists and laboratory medicine professionals. This approach to creating value in patient health care is more productive and sustainable ethically, morally and economically as a long-term strategy. It can be successfully achieved by applying defined rules that make public-private cooperation clearer, skipping incompatible solutions such as transforming clinical laboratories to 'industrially productive premises', outsourcing laboratory medicine services and using central acquisition of diagnostic systems.

Original languageEnglish
Pages (from-to)202-204
Number of pages3
JournalClinica Chimica Acta
Volume427
DOIs
Publication statusPublished - Jan 1 2014

Fingerprint

Health care
Medicine
Delivery of Health Care
Costs and Cost Analysis
Costs
Clinical laboratories
Public-Private Sector Partnerships
Outsourced Services
Outsourcing
Biomarkers
Pathology
Purchasing
Precision Medicine
Clinical Pathology
Health Resources
Health Expenditures
Health Care Costs
Patient Care
Technology
Pressure

Keywords

  • Decision making
  • Diagnostic industry
  • Health care cost-containment
  • Laboratory medicine
  • Managed care

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Biochemistry, medical
  • Medicine(all)

Cite this

@article{e80dc2dae2b94ace8d5709c7688ba1dc,
title = "An alternative perspective on how laboratory medicine can contribute to solve the health care crisis: A model to save costs by acquiring excellence in diagnostic systems",
abstract = "The rapid escalation in health care costs has led to the idea to deliver better care at lower costs, reshaping the responsibilities of the health care system to achieve the goal of creating value for the patient. The pressure for fiscal containment and the progressive reduction in available health care resources originated very short term strategies consisting of abrupt reductions in expenditure, specifically in the provision of clinical pathology laboratory medicine services. However, the impact of laboratory test results on diagnostic and therapeutic interventions has increased enormously in the past decade, due to advances in personalized medicine and to the strictly correlated requirement to use new biomarkers with increasing sensitivity and specificity in clinical practice. In order to create savings by delivering better care there is the need to invest financial resources in purchasing high technology and new sophisticated tests and to promote the expertise of clinical pathologists and laboratory medicine professionals. This approach to creating value in patient health care is more productive and sustainable ethically, morally and economically as a long-term strategy. It can be successfully achieved by applying defined rules that make public-private cooperation clearer, skipping incompatible solutions such as transforming clinical laboratories to 'industrially productive premises', outsourcing laboratory medicine services and using central acquisition of diagnostic systems.",
keywords = "Decision making, Diagnostic industry, Health care cost-containment, Laboratory medicine, Managed care",
author = "Michele Mussap",
year = "2014",
month = "1",
day = "1",
doi = "10.1016/j.cca.2013.09.034",
language = "English",
volume = "427",
pages = "202--204",
journal = "Clinica Chimica Acta",
issn = "0009-8981",
publisher = "Elsevier",

}

TY - JOUR

T1 - An alternative perspective on how laboratory medicine can contribute to solve the health care crisis

T2 - A model to save costs by acquiring excellence in diagnostic systems

AU - Mussap, Michele

PY - 2014/1/1

Y1 - 2014/1/1

N2 - The rapid escalation in health care costs has led to the idea to deliver better care at lower costs, reshaping the responsibilities of the health care system to achieve the goal of creating value for the patient. The pressure for fiscal containment and the progressive reduction in available health care resources originated very short term strategies consisting of abrupt reductions in expenditure, specifically in the provision of clinical pathology laboratory medicine services. However, the impact of laboratory test results on diagnostic and therapeutic interventions has increased enormously in the past decade, due to advances in personalized medicine and to the strictly correlated requirement to use new biomarkers with increasing sensitivity and specificity in clinical practice. In order to create savings by delivering better care there is the need to invest financial resources in purchasing high technology and new sophisticated tests and to promote the expertise of clinical pathologists and laboratory medicine professionals. This approach to creating value in patient health care is more productive and sustainable ethically, morally and economically as a long-term strategy. It can be successfully achieved by applying defined rules that make public-private cooperation clearer, skipping incompatible solutions such as transforming clinical laboratories to 'industrially productive premises', outsourcing laboratory medicine services and using central acquisition of diagnostic systems.

AB - The rapid escalation in health care costs has led to the idea to deliver better care at lower costs, reshaping the responsibilities of the health care system to achieve the goal of creating value for the patient. The pressure for fiscal containment and the progressive reduction in available health care resources originated very short term strategies consisting of abrupt reductions in expenditure, specifically in the provision of clinical pathology laboratory medicine services. However, the impact of laboratory test results on diagnostic and therapeutic interventions has increased enormously in the past decade, due to advances in personalized medicine and to the strictly correlated requirement to use new biomarkers with increasing sensitivity and specificity in clinical practice. In order to create savings by delivering better care there is the need to invest financial resources in purchasing high technology and new sophisticated tests and to promote the expertise of clinical pathologists and laboratory medicine professionals. This approach to creating value in patient health care is more productive and sustainable ethically, morally and economically as a long-term strategy. It can be successfully achieved by applying defined rules that make public-private cooperation clearer, skipping incompatible solutions such as transforming clinical laboratories to 'industrially productive premises', outsourcing laboratory medicine services and using central acquisition of diagnostic systems.

KW - Decision making

KW - Diagnostic industry

KW - Health care cost-containment

KW - Laboratory medicine

KW - Managed care

UR - http://www.scopus.com/inward/record.url?scp=84888861830&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84888861830&partnerID=8YFLogxK

U2 - 10.1016/j.cca.2013.09.034

DO - 10.1016/j.cca.2013.09.034

M3 - Article

VL - 427

SP - 202

EP - 204

JO - Clinica Chimica Acta

JF - Clinica Chimica Acta

SN - 0009-8981

ER -